Galapagos NV Files 6-K, Incorporates Press Release
Ticker: GLPGF · Form: 6-K · Filed: Dec 9, 2024 · CIK: 1421876
| Field | Detail |
|---|---|
| Company | Galapagos NV (GLPGF) |
| Form Type | 6-K |
| Filed Date | Dec 9, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, press-release
TL;DR
Galapagos NV filed a 6-K on Dec 9, incorporating a Dec 7 press release into its S-8 filings.
AI Summary
Galapagos NV filed a Form 6-K on December 9, 2024, reporting for the month of December 2024. The filing incorporates by reference a press release issued on December 7, 2024, as Exhibit 99.1, into its existing S-8 registration statements. The company is based in Mechelen, Belgium.
Why It Matters
This filing indicates Galapagos NV is providing updated information to the SEC, potentially related to ongoing business activities or disclosures that are being incorporated into its existing registration statements for employee stock plans.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that incorporates a press release, typically containing standard corporate information and not indicating significant new risks.
Key Numbers
- 20241207 — Press Release Date (Date the press release was issued, which is incorporated by reference.)
- 20241209 — Filing Date (Date the Form 6-K was filed with the SEC.)
Key Players & Entities
- GALAPAGOS NV (company) — Registrant
- 001-37384 (company) — SEC File Number
- 2800 MECHELEN (company) — City
- Marie José Kersten, MD (person) — Quoted in Exhibit 99.1
- Jeevan Shetty, MD (person) — Quoted in Exhibit 99.1
FAQ
What is the purpose of incorporating Exhibit 99.1 into the Form S-8 registration statements?
The filing states that the information in Exhibit 99.1 is incorporated by reference into the Company's Registration Statements on Form S-8, which are typically used for employee stock plans.
When was the press release incorporated by this filing issued?
The press release, Exhibit 99.1, was issued on December 7, 2024.
What is the primary business of Galapagos NV?
The filing lists the Standard Industrial Classification as 'PHARMACEUTICAL PREPARATIONS [2834]'.
Where is Galapagos NV headquartered?
Galapagos NV is headquartered in Mechelen, Belgium, with its principal executive office located at Generaal De Wittelaan L11 A3, 2800 Mechelen.
What type of SEC filing is this?
This is a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Filing Stats: 227 words · 1 min read · ~1 pages · Grade level 11.3 · Accepted 2024-12-09 07:37:27
Filing Documents
- f6k_120724.htm (6-K) — 8KB
- exh_991.htm (EX-99.1) — 13KB
- 0001171843-24-006806.txt ( ) — 22KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GALAPAGOS NV (Registrant) Date: December 9, 2024 /s/ Annelies Denecker Annelies Denecker Company Secretary